← Back
Data updated: Mar 10, 2026
SOBI
OncologyImmunologyDermatology
SOBI is a pharmaceutical company focused on Oncology, Immunology, Dermatology. Key products include VONJO.
2022
Since
1
Drugs
-
Trials
3
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 65%
0 drugs Phase 3: 1 Phase 1: 9
Immunology 15%
0 drugs Phase 1: 3
Dermatology 15%
0 drugs Phase 2: 1 Phase 1: 1
Metabolic 5%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-02-28
- Latest
- 2025-10-01
- Applications
- 1